Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease

被引：22
|
作者：
Kwon, Young-Man [1 ,2 ]
Hwang, Hye Suk [1 ,2 ]
Lee, Jong Seok [1 ,2 ]
Ko, Eun-Ju [1 ,2 ]
Yoo, Si-Eun [1 ,2 ]
Kim, Min-Chul [3 ]
Lee, Yu-Na [1 ,2 ]
Kim, Ki-Hye [1 ,2 ]
Song, Jae-Min [4 ]
Lee, Sujin [5 ,6 ]
Moore, Martin L. [5 ,6 ]
Kang, Sang-Moo [1 ,2 ]
机构：
[1] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA
[2] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
[3] Anim & Plant Quarantine Agcy, Anyang, Gyeonggi Do, South Korea
[4] Sungshin Womens Univ, Dept Global Med Sci, Seoul, South Korea
[5] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[6] Childrens Healthcare Atlanta, Atlanta, GA USA
来源：
ANTIVIRAL RESEARCH | 2014年 / 104卷
关键词：
Maternal antibodies; FI-RSV; Passive immunization; Vaccine enhanced disease; PULMONARY INFLAMMATORY RESPONSE; T-CELL RESPONSES; COTTON RATS; RSV VACCINE; G PROTEIN; INFECTION; MICE; PALIVIZUMAB; EOSINOPHILIA; CHALLENGE;
D O I：
10.1016/j.antiviral.2014.01.008
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Maternal immunization of mice with formalin inactivated respiratory syncytial virus (FI-RSV) resulted in the passive transfer of RSV antibodies but not cellular components to the offspring. The offspring born to FI-RSV immunized mothers showed serum RSV neutralizing activity, effectively controlled lung viral loads without vaccine-enhanced disease, did not induce pulmonary eosinophilia, and cytokine producing cells after live RSV infection. Therefore, this study provides evidence that maternal immunization provides an in vivo model in investigating the roles of antibodies independent of cellular components. (c) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码：1 / 6
页数：6
相关论文
共 50 条
  • [1] Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV
    Johnson, TR
    Teng, MN
    Collins, PL
    Graham, BS
    JOURNAL OF VIROLOGY, 2004, 78 (11) : 6024 - 6032
  • [2] Th2-independent development of vaccine-enhanced disease associated with formalin-inactivated respiratory syncytial virus immunization
    Knudson, Cory
    Hartwig, Stacey
    Meyerholz, David
    Varga, Steven
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [3] Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease
    Elaine M. Castilow
    Matthew R. Olson
    Steven M. Varga
    Immunologic Research, 2007, 39 : 225 - 239
  • [4] Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease
    Castilow, Elaine M.
    Olson, Matthew R.
    Varga, Steven M.
    IMMUNOLOGIC RESEARCH, 2007, 39 (1-3) : 225 - 239
  • [5] Vβ14+ T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV
    Johnson, TR
    Varga, SM
    Braciale, TJ
    Graham, BS
    JOURNAL OF VIROLOGY, 2004, 78 (16) : 8753 - 8760
  • [6] A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease
    Lindell, Dennis M.
    Morris, Susan B.
    White, Maria P.
    Kallal, Lara E.
    Lundy, Phillip K.
    Hamouda, Tarek
    Baker, James R., Jr.
    Lukacs, Nicholas W.
    PLOS ONE, 2011, 6 (07):
  • [7] Immune responses to respiratory syncytial virus (RSV) G glycoprotein are not necessary for formalin-inactivated RSV (FI-RSV) vaccine-enhanced disease
    Johnson, TR
    Collins, PL
    Teng, MN
    Graham, BS
    FASEB JOURNAL, 2003, 17 (07): : C24 - C24
  • [8] Fas Ligand Is Required for the Development of Respiratory Syncytial Virus Vaccine-Enhanced Disease
    Olson, Matthew R.
    Varga, Steven M.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (05): : 3024 - 3031
  • [9] Separation of pulmonary and systemic aspects of respiratory syncytial virus vaccine-enhanced disease
    Castilow, Elaine
    Varga, Steven M.
    FASEB JOURNAL, 2008, 22
  • [10] Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus
    Hwang, Bye Suk
    Lee, Young-Tae
    Kim, Ki-Hye
    Ko, Eun-Ju
    Lee, Youri
    Kwon, Young-Man
    Kang, Sang-Moo
    VIROLOGY, 2017, 511 : 142 - 151
12345